Shenzhen Neptunus Bioengineering Co., Ltd. (000078)

Overview

Founded in 1989 and headquartered in Shenzhen, China, Shenzhen Neptunus Bioengineering Co., Ltd. is a leading company that specializes in the research and development, production, and sales of a wide range of pharmaceutical products. The core focus of the company is on Chinese patent medicines, infusion products, and western medicine preparations. Shenzhen Neptunus Bioengineering Co., Ltd. is dedicated to advancing the healthcare industry in China through innovation and high-quality products. Its commitment to excellence is underpinned by robust research and development work, including the provision of technical support for generic drug quality consistency evaluations. In addition to its pharmaceutical production, the company plays a vital role in the distribution of drugs, medical devices, and other medical supplies. It also provides value-added services to hospitals, medical institutions, and drug retail institutions and distributors, emphasizing its comprehensive approach to healthcare solutions.

Products and Services

• Oryzanol Tablets: These tablets are used for various health benefits including the management of high cholesterol levels. Oryzanol, derived from rice bran oil, is known for its antioxidant properties that contribute to cardiovascular health.
• Chlorpheniramine Tablets and Chlorpheniramine Maleate Tablets: Both products serve as antihistamines used to relieve symptoms of allergy, hay fever, and the common cold. These include symptoms such as rash, itching, watery eyes, itchy eyes/nose/throat, cough, runny nose, and sneezing.
• Rifampicin Capsules: These capsules are used primarily to treat or prevent tuberculosis (TB). Rifampicin can be used alone or with other drugs to treat various bacterial infections.
• Generic Drug Quality Consistency Evaluation: Shenzhen Neptunus Bioengineering provides technical support for this crucial evaluation process, ensuring that generic drugs meet the same standards of quality, safety, and efficacy as brand-name drugs.
• Medical Research and Development: The company engages in extensive R&D work, focusing on new drugs for malignant tumors, cardiovascular and cerebrovascular diseases, neurodegenerative diseases, diabetes, infectious diseases, and diseases affecting the respiratory and digestive systems.
• Distribution Services: Beyond manufacturing, Shenzhen Neptunus Bioengineering distributes drugs, medical devices, and medical supplies, catering to the needs of hospitals, medical institutions, and drug retailers.
• Value-Added Services: The company offers a suite of value-added services for healthcare institutions and drug distributors, including logistics, information management, and consulting services, reinforcing its commitment to support the healthcare ecosystem comprehensively.